Lethal opioids or dangerous prescribers?

Palliative Medicine

Volumn 21, Issue 2, 2007, Pages 77-80

  George, Rob ^a   Regnard, Claud ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BENZODIAZEPINE DERIVATIVE; MORPHINE; NARCOTIC ANALGESIC AGENT; SEDATIVE AGENT;

CANCER PAIN; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG MEGADOSE; DYSPNEA; EDITORIAL; EUTHANASIA; HEALTH BELIEF; HUMAN; MALPRACTICE; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICOLEGAL ASPECT; NETHERLANDS; NONHUMAN; PALLIATIVE THERAPY; PATIENT CARE; PHYSICIAN ATTITUDE; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; RESPIRATION DEPRESSION; RISK BENEFIT ANALYSIS; TERMINAL CARE;

ANALGESICS, OPIOID; NARCOTICS; PAIN, INTRACTABLE; PALLIATIVE CARE; PROFESSIONAL PRACTICE;

EID: 33947361220     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269216307076714     Document Type: Editorial

References (43)

1. Sykes NA. Thorns. Sedative use in the last week of life and the implications for end-of-life decision making. Arch. Int. Med. 2003; 163: 341-4.
2. Ahmedzai SH. Window of opportunity for pain control in the terminally ill. Lancet 2001; 357: 1304-5.
3. Anonymous. The persistent problem with pain. Lancet 2001; 357: 1217.
4. Borgbjerg F, Nielsen K, Franks J. Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers. Pain 1996; 64: 123-8.
5. Corkery JM, Hamid Ghodse FS, Adenekan Oyefeso A. The effects of methadone and its role in fatalities. Hum Psychopharmacol: Clin Exp 2004; 19: 565-76.
6. Fohr S. The double effect of pain medication: separating myth from reality. J Palliat Med 1998; 1: 315-28.
7. Gilbert J, Kirkham S. Double effect, double bind or double speak?. Palliat Med 1999; 13: 365-6.
8. Good PR, Cavenagh J. Effects of opioids and sedatives on survival in an Australian inpatient palliative care population. Int Med J 2005; 35: 512-7.
9. Hill CSOsl. The barriers to adequate pain management with opioid analgesics. Sem Oncol. 20(SuppI 1): 1-5.
10. Levy M. Pain management in advanced cancer. Sem Oncol 1984; 12: 394-410.
11. McQuay H. Opioids in pain management. Lancet 1999; 353: 2229-32.
12. Morita TT, Inoue J, Chihara S. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Sympt Manag 2001; 21: 282-9.
13. Portenoy R. Appropriate use of opioids for persistent non-cancer pain. Lancet 2004; 364: 739-40.
14. Portenoy R, Lesage P. Management of cancer pain. The Lancet 1999; 353: 1695-700.
15. Portenoy RK, Coyle N. Controversies in the long-term management of analgesic therapy in patients with advanced cancer. J Pain Sympt Manag 1990; 5: 307-19.
16. Regnard C, Badger C. Opioids, Sleep and the time of death, Palliat Med 1987; 1: 107-10.
17. Thorns A. More openness needed in palliative care. Doctrine of double effect means that death is not intended. BMJ 1998; 316: 391.
18. Thorns A, Sykes N. Opioid use in last week of life and implications for end-of-life decision-making. Lancet 2000; 356: 398-9.
19. Turner K, Chye R, Aggarwal G, Philip J, Skeels A, Lickiss JN. Dignity in dying: a preliminary study of patients in the last three days of life. J Palliat Care 1996; 12: 7-13.
20. Twycross R. Ethical and clinical aspects of pain treatment in cancer patients. Acta Anaesthesiologica Scandinavia 1982; 74(Suppl): 83-90.
21. Wall P. The generation of yet another myth on the use of narcotics. Pain 1997; 73: 121-2.
22. Walsh T. Opiates and respiratory function in advanced cancer. Recent Results Cancer Res 1984; 41: 115-7.
23. Hanks G, Cherny N, Fallon M. Opioid analgesic therapy. In Doyle D. et al., eds. Oxford Textbook of Palliative Medicine. Oxford University Press, 2004: 316-41.
24. Portenoy R. Opioid use and survival at the end of life: a survey of a hospice population. J Pain Symp Manag 2006; 32: 532-40.
25. Chan J, Treece PD, Engelberg RA, et al. Narcotic and benzodiazepine use after withdrawal of life support: association with time to death?. Chest, 2004; 126: 286-93.
26. Edwards M. Opioids and benzodiazepines appear paradoxically to delay inevitable death after ventilator withdrawal. J Palliat Care, 2005; 21: 299-302.
27. Estfan B, Mahmoud F, Shaheen P, et al. Respiratory function during parenteral opioid titration for cancer pain. Palliat Med 2007: 21: 81-86.
28. Hu WC, Cheng TY, Chen CY. Morphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan? J Pain Symp Manag 2004; 28: 356-63.
29. Mazzocato CBT, Rapin CH. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Annals Oncol 1999; 10: 1511-4.
30. Boyd K, Kelly M. Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer. Palliat Med 1997; 11: 277-81.
31. Bruera E, Macmillan K, Pither RT, McDonald RN. Effects of morphine on the dyspnoea of terminal cancer patients. J Pain Sympt Manag 1990; 5: 341-44.
32. Rurup M, Onwuteaka-Philipsen BD, van der Heide A, van der Wal G, van der Mass PJ. Trends in the agents used for euthanasia and the relationship with the number of notifications. Nederlands Tijdschrift voor Geneeskunde 2006; 150: 618-24.
33. Schmidt C. Carotid sinus reflexes to the respiratory centre: I. Identification. Am J Physiol 1932; 102: 94-119.
34. Devlin JRv. Adams (Bodkin), in Crim. Law Rev. 1957.
35. Dyer C. British GP cleared of murder charge. BMJ 1999; 318: 1306a.
36. Walton of Detchant, L., Select Committee on Medical Ethics Report. 1994, House of Lords: The Stationary Office. p. 3 vols.
37. Seale C. National survery of end-of-life decisions made by UK medical practitioners. Palliat Med 2006; 20: 3-10.
38. Seale C. Characteristics of end-of-life decisions: survey of UK medical practitioners. Palliat Med 2006; 20: 653-9.
39. Kuhse H, Singer P, Braume P, Clark M, Richard M. End-of-life decisions in Australian medical practice. Med J Aust 1997; 166: 191-6.
40. van der Heide A, et al. End-of-life decision-making in six European countries: descriptive study. Lancet 2003; 362: 345-50.
41. Forbes K, Huxtable R. Clarifying the data on double effect. Palliat Med, 2006; 20: 395.
42. Ashby M. The fallacies of death causation in palliative care. Med J Aust, 1997; 166: 176-7.
43. Doyal L. When doctors might kill their patients: The moral character of doctors or the best interests of patients? BMJ 1999; 318: 1432-3.